Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

FDA's Role In Genetic Test Reports Debated At Public Meeting

This article was originally published in The Gray Sheet

Executive Summary

An FDA meeting drew a variety of perspectives on the formatting of genetic test results, with participants trying to balance patient safety with their right to know. One popular suggestion at the gathering was the use of tiered reports, where test results and information could be segmented based on target audience or amount of supporting evidence.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT034577

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel